Basit öğe kaydını göster

dc.contributor.authorYagmur, Caglayan
dc.contributor.authorAkaishi, Satoshi
dc.contributor.authorOgawa, Rei
dc.contributor.authorGuneren, Ethem
dc.date.accessioned2020-06-21T14:47:34Z
dc.date.available2020-06-21T14:47:34Z
dc.date.issued2010
dc.identifier.issn0032-1052
dc.identifier.issn1529-4242
dc.identifier.urihttps://doi.org/10.1097/PRS.0b013e3181df715d
dc.identifier.urihttps://hdl.handle.net/20.500.12712/17813
dc.descriptionGuneren, Ethem/0000-0002-5981-7010en_US
dc.descriptionWOS: 000280143800010en_US
dc.descriptionPubMed: 20375759en_US
dc.description.abstractBackground: The physiopathogenesis of proliferative scarring in human skin is not well understood. Furthermore, knowledge of the precise mechanisms of action for physical treatment modalities is limited Compression garments, occlusive/adhesive skin taping, and silicone gel sheets are applied to form an occlusion on the scar surface, reduce tension, and/or increase pressure on the scar itself. The mechanisms by which the external or superficial actions of these treatments cause remission of a protruding scar may be related to mechanoreceptor (nociceptor and cellular mechanoreceptor) responses. Methods: Basic research studies about mechanoreceptor-related (nociceptors and cellular mechanoreceptors, separately) events are reviewed and discussed based on proliferative scarring background. Scar management related studies were corrected from the standpoint of mechanotransduction mechanisms. The methodologic quality of the clinical trials and basic studies was evaluated and reviewed. Results: it was suggested that many of the physical scar management methods, including compression therapy, silicone therapy, adhesive tape, and occlusive dressing therapy, are related to mechanotransduction mechanisms. Conclusions: A unifying perspective of basic research findings and clinical observations may be obtained by considering the mechanoreceptor-related events in scar management. Moreover, a precise understanding of the roles that cellular mechanoreceptors and mechanosensitive nociceptors play in proliferative scarring may lead to the development of innovative treatment strategies and new pharmacologic therapies targeting cellular mechanoreceptors and mechanosensitive nociceptors in fibroproliferative diseases. (Plast. Reconstr. Surg. 126. 426, 2010.)en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.isversionof10.1097/PRS.0b013e3181df715den_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMechanical Receptor-Related Mechanisms in Scar Management: A Review and Hypothesisen_US
dc.typereviewen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume126en_US
dc.identifier.issue2en_US
dc.identifier.startpage426en_US
dc.identifier.endpage434en_US
dc.relation.journalPlastic and Reconstructive Surgeryen_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster